Discovery of novel Rho kinase inhibitors: Hit generation and lead optimization

被引：0

作者：

Alexander, Brian G. ^{[1
]}

Pireddu, Roberta ^{[1
]}

Sun, Nan N. ^{[1
]}

Yu, Huidong ^{[1
]}

Forinash, Kara D. ^{[1
]}

Martin, Matthew P. ^{[1
]}

Schonbrunn, Ernst ^{[1
]}

Guida, Wayne C. ^{[1
]}

Sebti, Said M. ^{[1
]}

Lawrence, Nicholas J. ^{[1
]}

机构：

[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA

来源：

CANCER RESEARCH | 2011年 / 71卷

关键词：

D O I：

10.1158/1538-7445.AM2011-3243

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3243

引用

页数：2

共 50 条

[11] Novel selective inhibitors of neutral endopeptidase: discovery by screening and hit-to-lead optimisation
El Bakali, Jamal
Maingot, Lucie
Dumont, Julie
Host, Helene
Hocine, Akila
Cousaert, Nicolas
Dassonneville, Sandrine
Leroux, Florence
Deprez, Benoit
Deprez-Poulain, Rebecca
MEDCHEMCOMM, 2012, 3 (04) : 469 - 474
[12] Discovery of pyrazolo[1,5-a]pyrimidin-7-amine derivatives as mTOR kinase domain inhibitors: Hit to lead optimization
Deng, Yongqi
Sun, Binyuan
Shipps, Gerald
Matthew, Richards
Meng, Zhaoyang
Windsor, Williama
Zeng, Hongbo
Long, Brian
Xiao, Li
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
[13] Novel oxindole inhibitors of Aurora A kinase: Structure based hit-to-lead approach
Pireddu, Roberta
Lawrence, Harshani R.
Martin, Mathew P.
Betzi, Stephane
Yip, Richard
Yang, Hua
Sun, Nan N.
Cheng, Jin Q.
Schonbrunn, Ernst
Sebti, Said M.
Lawrence, Nicholas J.
CANCER RESEARCH, 2011, 71
[14] HTS identification and optimization of Rho Kinase inhibitors
Hobson, Adrian D.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
[15] Advantages of fluorinated fragment library in the discovery of novel specific binders and hit to lead optimization
Gavrylenko, Oleksii
Moroz, Yurii
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
[16] Discovery and hit-to-lead optimization of 2,6-diaminopyrimidine inhibitors of interleukin-1 receptor-associated kinase 4
McElroy, William T.
Seganish, W. Michael
Herr, R. Jason
Harding, James
Yang, Jinhai
Yet, Larry
Komanduri, Venukrishnan
Prakash, Koraboina Chandra
Lavey, Brian
Tulshian, Deen
Greenlee, William J.
Sondey, Christopher
Fischmann, Thierry O.
Niu, Xiaoda
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (09) : 1836 - 1841
[17] Discovery and optimization of novel phenyldiazepine and pyridodiazepine based Aurora kinase inhibitors
Tamizharasan, Natarajan
Gajendran, Chandru
Kristam, Rajendra
Sulochana, Suresh P.
Sivanandhan, Dhanalakshmi
Mullangi, Ramesh
Mathivathanan, Logesh
Hallur, Gurulingappa
Suresh, Palaniswamy
BIOORGANIC CHEMISTRY, 2020, 99
[18] Discovery of potent dipeptidyl peptidase IV inhibitors through pharmacophore hybridization and hit-to-lead optimization
Zeng, Shaogao
Xie, Hui
Zeng, Li-li
Lu, Xin
Zhao, Xin
Zhang, Gui-cheng
Tu, Zheng-chao
Xu, Hong-jiang
Yang, Ling
Zhang, Xi-quan
Hu, Wenhui
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (07) : 1749 - 1755
[19] Lead generation - Enhancing the success of drug discovery by investing in the hit to lead process
Alanine, A
Nettekoven, M
Roberts, E
Thomas, AW
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2003, 6 (01) : 51 - 66
[20] MEDI 356-Hit to lead account of the discovery of a new class of inhibitors of Pim-2 kinase
Prokopowicz, Anthony S., III
Morwick, Tina
Cywin, Charles L.
Qian, Kevin
Mao, Wang
Wolak, John P.
Peng, Charlene
Kashem, Mohammed A.
Li, Jun
Wang, Lian
Jakes, Scott
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236

← 1 2 3 4 5 →